Bristol Myers | search
Click here to view Bristol Myers news from 60+ newspapers.
Bookmark or Share- Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio ...Through this acquisition, Bristol Myers Squibb will add KRAZATI, an important lung cancer medicine, to its commercial portfolio. The company gains access to several promising clinical assets that complement its oncology pipeline and are strong candidates for single agent development and combination strategies.
- BMY financial reporting - Bristol Myers SquibbExplore comprehensive information on Bristol Myers Squibb reports, earnings, product sales, SEC filings and more to help you make an informed investment decision.
- Products and medicines - Bristol Myers SquibbBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.
- Global Biopharmaceutical Company - Bristol Myers SquibbBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a ...Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders.
More
